Exosome-based therapy and targeted PROTAC delivery: A new nanomedicine frontier for HPV-mediated cervical cancer treatment

Nobendu Mukerjee, Swastika Maitra, Arabinda Ghosh

PDF
Clinical and Translational Discovery ›› 2024, Vol. 4 ›› Issue (4) : e328. DOI: 10.1002/ctd2.328
COMMENTARY

Exosome-based therapy and targeted PROTAC delivery: A new nanomedicine frontier for HPV-mediated cervical cancer treatment

Author information +
History +

Cite this article

Download citation ▾
Nobendu Mukerjee, Swastika Maitra, Arabinda Ghosh. Exosome-based therapy and targeted PROTAC delivery: A new nanomedicine frontier for HPV-mediated cervical cancer treatment. Clinical and Translational Discovery, 2024, 4(4): e328 https://doi.org/10.1002/ctd2.328

References

[1]
Khan I, Harshithkumar R, More A, Mukherjee A. Human papilloma virus: an unraveled enigma of universal burden of malignancies. Pathogens. 2023;12(4):564.
[2]
Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat. 2005;37(6):319-324.
[3]
Burmeister CA, Khan SF, Schäfer G, et al. Cervical cancer therapies: current challenges and future perspectives. Tumour Virus Res. 2022;13:200238.
[4]
Maitra S, Mukerjee N, Alharbi HM, Ghosh A, Alexiou A, Thorat ND. Targeted therapies for HPV-associated cervical cancer: harnessing the potential of exosome-based chipsets in combating leukemia and HPV-mediated cervical cancer. J Med Virol. 2024;96(4):e29596.
[5]
Wang C, Zhang Y, Chen W, et al. New-generation advanced PROTACs as potential therapeutic agents in cancer therapy. Mol Cancer. 2024;23:110.
[6]
Mukerjee N, Maitra S, Ghosh A, Subramaniyan V, Sharma R. Exosome-mediated PROTACs delivery to target viral infections. Drug Dev Res. 2023;84(6):1031-1036.
[7]
Koh HB, Kim HJ, Kang SW, Yoo TH. Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics. 2023;15(8):2042.
[8]
Aqil F, Gupta RC. Exosomes in cancer therapy. Cancers (Basel). 2022;14(3):500.
[9]
Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8(7):727.
[10]
Lee YJ, Shin KJ, Chae YC. Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med. 2024;56:877-889.
[11]
Danishuddin , Jamal MS, Song KS, Lee KW, Kim JJ, Park YM. Revolutionizing drug targeting strategies: integrating artificial intelligence and structure-based methods in PROTAC development. Pharmaceuticals. 2023;16(12):1649.
CrossRef Google scholar

RIGHTS & PERMISSIONS

2024 2024 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
PDF

Accesses

Citations

Detail

Sections
Recommended

/